Vimarsana
Biggest News Aggregation in the World

Page 41 - Xtend News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xtend. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xtend Today - Breaking & Trending Today

Evotec and Bristol Myers Squibb extend and expand strategic neurodegeneration partnership - Vimarsana News

Evotec and Bristol Myers Squibb extend and expand strategic neurodegeneration partnership

EQS-News: Evotec SE / Key word: Miscellaneous Evotec and Bristol Myers Squibb extend and expand strategic neurodegeneration partnership 28.03.2023 / 11:02 CET/CEST The issuer is... | March 28, 2023

Evotec SE: Evotec and Bristol Myers Squibb Extend and Expand Strategic Neurodegeneration Partnership - Vimarsana News

Evotec SE: Evotec and Bristol Myers Squibb Extend and Expand Strategic Neurodegeneration Partnership

8-YEAR EXTENSION AND EXPANSION OF ONGOING COLLABORATION TO DEVELOP A BROADENED PROGRAMME PIPELINE IN NEURODEGENERATIVE DISEASESPARTNERSHIP LEVERAGES EVOTEC'S PRECISION MEDICINE PLATFORMSFINANICAL TERMS

Ontrak Health Will Bring MyndYou's AI-Powered, Active Listening Virtual Care Assistant to Its Behavioral Health Members - Vimarsana News

Ontrak Health Will Bring MyndYou's AI-Powered, Active Listening Virtual Care Assistant to Its Behavioral Health Members

MyndYou’s MyEleanor will extend Ontrak Health’s ability to identify and engage members, using AI to triage and address mental health needs ... | March 28, 2023

Veritone Extends Partnership with Augusta National, Delivering Brand Exposure and Boosting Archival Revenue - Vimarsana News

Veritone Extends Partnership with Augusta National, Delivering Brand Exposure and Boosting Archival Revenue

Experts in rights management, licensing and monetization extend multi-year partnership as North American licensing agent for the Masters Tournament ... | March 28, 2023

Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis - Vimarsana News

Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis

WILMETTE, Ill., March 27, 2023 -- Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the... | March 27, 2023